Biologics of Lumbar Interbody Fusion

Gurmit Singh, Wellington K. Hsu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Lumbar interbody spine fusion is increasingly utilized for treatment of a variety of spinal pathologies. The utilization of biologics in this space has gained significant interest from both—a research and clinical perspective. Historically, iliac crest bone graft has been the gold standard for lumbar interbody spine fusion, however, to avoid donor site morbidity, other options for bone graft substitutes are now commercially available. These include allograft, demineralized bone matrix, ceramics, and recombinant growth factors. More data is needed to assess clinical efficacy of mesenchymal stem cells, platelet rich plasma and peptides.

Original languageEnglish (US)
Pages (from-to)194-202
Number of pages9
JournalSeminars in Spine Surgery
Issue number4
StatePublished - Dec 2018

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine


Dive into the research topics of 'Biologics of Lumbar Interbody Fusion'. Together they form a unique fingerprint.

Cite this